We will contact you shortly.
Stem cell therapy can reduce the symptoms of hormonal disorders and restore normal potency in hypogonadism.
Hypogonadism is a disease that significantly reduces the quality of life. 50% of sick men ignore the symptoms of the disease, which can lead to infertility and accelerated aging.
Roman Sulik, MD, coordinator of cell therapy programs, neurologist of the highest qualification category.
Hypogonadism (androgen deficiency) is a pathological sex hormones production decrease and impaired development of the genitals. Primary hypogonadism is a disorder of the genitals tissues (testicles and ovaries). Secondary hypogonadism (or hypogonadotropic hypogonadism) occurs due to dysfunction of the pituitary gland — the main endocrine gland.
GOOD CELLS doctors offer an individual treatment program to correct hormonal disorders and, as a consequence, to reduce the manifestations of hypogonadism. Depending on the type of disease, the patient is prescribed only intravenous or intravenous and local injections.
Cell types for the treatment of hypogonadism:
● neural crest-derived multipotent stem cells (NC-MSCs);
● mesenchymal stem cells from adipose tissue (ADSCs);
● umbilical cord multipotent mesenchymal stem cells (UC-MSCs).
Cell therapy against hypogonadism
This treatment is indicated for men over 18 years diagnosed with primary or secondary hypogonadism.
● oncological diseases or their presence in the anamnesis for the last five years;● psychiatric disorders;● alcohol or drug addiction.
How to improve potency with cell therapy?
The treatment strategy depends on the origin of the problem. If hypogonadism is secondary and appeared as a result of another disease, the treatment and selection of stem cells depends on the initial pathology.
Selection of cell therapy for secondary hypogonadism will be determined in accordance with the mechanisms of its formation. Improving the neuroendocrine mechanism is due to improving the sensitivity of receptors to hormones by releasing neurosecretory factors that affect both the central link (brain and its neuroendocrine function) and peripheral endocrine link. Thus, cell therapy improves balance and regulates the reverse axis in hypogonadism and the release of sex hormones.
In primary hypogonadism, first of all, the possibility of traditional treatment is considered and, if necessary, the cell therapy is provided to supplement and improve its results. The feasibility and effectiveness of cell therapy for primary hypogonadism is considered in each case individually.
1. Communication with a manager
Please contact our managers. It does not oblige you to anything. They will be glad to answer all your questions. At this stage, the manager will ask you to send your medical reports and the results of previous examinations so that the doctor can examine them and confirm the diagnosis. This is necessary to determine exactly how we can help you. Then you will be offered a free online consultation with a doctor or an appointment at the clinic.
2. Online/offline consultation with a doctor
During consultation with a doctor you will be able to find out all the details of the program, get a personal forecast of effectiveness. We will review all medical information you provide, as we must be confident that the treatment will be effective for you. The treatment program is developed individually.
3. Assessment of the patient's condition
The doctor will assess your readiness for cell therapy. In case of a positive assessment, depending on the doctor's recommendations, you may be prescribed your own or donor stem cells.
4. Preparation of the stem cell product
OWN CELLSIn the laboratory, specialists isolate, cultivate and test stem cells to verify their compliance with the minimum criteria for determining MSCs. Then the therapeutic dose and a quality passport are formed. Usually, the production period takes 21-28 days.
DONOR CELLSAccording to the doctor's prescription, the biotechnologist selects a ready-made sample of donor cells from our cryobank. All samples have been pre-tested for safety. In this case, the introduction of cells is possible after diagnosis and drug preparation. The production period takes 1-3 days.
5. Beginning of treatment
Any treatment course must include preliminary diagnostics, tests and examinations (spermogram, ultrasound, testicular biopsy, CT scan / MRI of the brain and other tests and screenings prescribed to you).
6. Injection of cellular product, regeneration phase
As a part of a treatment program, the doctor may prescribe intravenous cell therapy and endolumbar administration of the cell drug. The number of injections will depend on the patient's condition.
7. Medical conclusion and recommendations after treatment
At the end of the course you will be given a medical conclusion, which will indicate the diagnosis, the results of all examinations (clinical, laboratory and instrumental), methods of treatment and recommendations. Your doctor will make recommendations to maintain and improve your condition.
8. Stay in touch
After treatment, our patients must keep in touch with the clinic. In 3 and 6 month after treatment, our manager will contact you and offer to fill in a questionnaire, if necessary, talk to your doctor about the treatment results. Throughout the program, you will be in touch with a personal manager who will ensure easy communication between you and the doctor to monitor the dynamics of treatment.
What are the symptoms of hypogonadism?
The main symptoms of hypogonadism:
● decreased sexual activity, including the quality and quantity of erections, decreased / absent libido and orgasm.
● reduction in the size of the penis and testicles, changes in the appearance of the scrotum.
● disorders associated with secondary sexual characteristics: growth of the mammary glands (gynecomastia), the appearance of fat deposits on the thighs, buttocks, chest (female type), decreased amount of hair on the face and body.
At what age can I receive cell therapy to treat hypogonadism?
First of all, the doctor focuses on the type of hypogonadism, regardless of age: primary or secondary, in order to determine whether stem cell therapy is appropriate in each case.
Usually, we consider patients of pubertal age 16 years and older.